<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004080A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004080</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14004211</doc-number><date>20120309</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>38</main-group><subgroup>20</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>38</main-group><subgroup>2013</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>424 852</main-classification><further-classification>435  724</further-classification></classification-national><invention-title id="d0e43">USE OF LOW DOSE IL-2 FOR TREATING AUTOIMMUNE - RELATED OR INFLAMMATORY DISORDERS</invention-title><us-related-documents><us-provisional-application><document-id><country>US</country><doc-number>61451663</doc-number><date>20110311</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Klatzmann</last-name><first-name>David</first-name><address><city>Paris</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Saadoun</last-name><first-name>David</first-name><address><city>Neuilly Sur Seine</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Cacoub</last-name><first-name>Patrice</first-name><address><city>Le Pereux</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Rosenzwajg</last-name><first-name>Mich&#xe8;le</first-name><address><city>Paris</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="04" app-type="applicant" designation="us-only"><addressbook><last-name>Piaggio</last-name><first-name>Eliane</first-name><address><city>Paris</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="05" app-type="applicant" designation="us-only"><addressbook><last-name>Bensimon</last-name><first-name>Gilbert</first-name><address><city>Villejuif</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="06" app-type="applicant" designation="us-only"><addressbook><last-name>Bernard</last-name><first-name>Claude</first-name><address><city>Malakoff</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Klatzmann</last-name><first-name>David</first-name><address><city>Paris</city><country>FR</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Saadoun</last-name><first-name>David</first-name><address><city>Neuilly Sur Seine</city><country>FR</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Cacoub</last-name><first-name>Patrice</first-name><address><city>Le Pereux</city><country>FR</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Rosenzwajg</last-name><first-name>Mich&#xe8;le</first-name><address><city>Paris</city><country>FR</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Piaggio</last-name><first-name>Eliane</first-name><address><city>Paris</city><country>FR</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>Bensimon</last-name><first-name>Gilbert</first-name><address><city>Villejuif</city><country>FR</country></address></addressbook></inventor><inventor sequence="06" designation="us-only"><addressbook><last-name>Bernard</last-name><first-name>Claude</first-name><address><city>Malakoff</city><country>FR</country></address></addressbook></inventor></inventors></us-parties><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/EP12/54174</doc-number><kind>00</kind><date>20120309</date></document-id><us-371c124-date><date>20130910</date></us-371c124-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.</p></abstract></us-patent-application>